YD Bio Limited Ordinary Shares
YDES · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 45.8% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 30.4% | 43.8% | – | – |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -251% | 6.4% | – | – |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -276.6% | 3.9% | – | – |
| EPS Diluted | -0.56 | 0 | 0.41 | 0.59 |
| % Growth | -280,100% | -100% | -30.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |